View Labels for A Randomized, international double-blinded (with in house blinding), controlled with Gardasil TM, dose ranging, tolerability, immunogenicity and efficacy study of a multivalent human papillomavirus (HPV) L1 virus-like particle (VLP) vaccine administered to 16-26 year-old women.